Compounds > ecteinascidin 743
Page last updated: 2024-09-02

ecteinascidin 743 and Adrenal Cortex Cancer

ecteinascidin 743 has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abate, A; Basnet, RM; Berruti, A; Cosentini, D; Gianoncelli, A; Grisanti, S; Hantel, C; Laganà, M; Memo, M; Ribaudo, G; Rossini, E; Sigala, S; Tamburello, M; Tiberio, GAM1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Adrenal Cortex Cancer

ArticleYear
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models.
    Endocrine-related cancer, 2023, 02-01, Volume: 30, Issue:2

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Cell Line, Tumor; Humans; Matrix Metalloproteinase 2; Trabectedin

2023